Hypothesis

Age‑related depletion of indole‑3‑propionic acid (IPA) reduces pregnane X receptor (PXR) activity in prefrontal neurons, shifting the excitation‑inhibition balance toward excessive synaptic stabilization. This manifests as behavioral rigidity that we interpret as cognitive decay but is actually an over‑consolidated predictive model. Restoring IPA‑PXR signaling re‑introduces controlled uncertainty by lowering the threshold for synaptic updating, thereby improving reversal learning without needing to rebuild lost neurons.

Mechanistic Rationale

• Neuronal PXR modulates NMDA‑receptor composition – PXR activation upregulates the transcription factor Nr4a1, which suppresses Grin2a (GluN2A) and favors Grin2B (GluN2B) expression. GluN2B‑rich NMDA receptors have slower kinetics and higher calcium permeability, lowering the threshold for long‑term potentiation (LTP) induction and facilitating the incorporation of novel information.
• Astrocytic glutamate clearance – PXR in astrocytes increases expression of the glutamate transporter EAAT2 (Slc1a2). Enhanced uptake reduces extracellular glutamate spillover, preventing saturation of synaptic plasticity mechanisms and preserving a dynamic range for prediction‑error signaling.
• Microglial phenotype shift – PXR activation drives microglia toward a homeostatic state (increased P2ry12, decreased Cd68), lowering basal release of TNF‑α and IL‑1β. Reduced cytokine tone diminishes maladaptive metaplasticity that otherwise raises the LTP threshold and locks circuits into rigid firing patterns.

Together, these actions create a permissive milieu where unexpected sensory inputs can drive synaptic change, counteracting the over‑consolidation that characterizes aged cognition.

Testable Predictions

1. Behavioral – Aged mice (20‑24 mo) receiving chronic IPA supplementation (10 mg/kg/day, oral) will show improved performance in a probabilistic reversal learning task compared with vehicle controls. Improvement will be absent in mice with neuron‑specific PXR knockout (Camk2a‑Cre;Pxr^fl/fl).
2. Molecular – IPA‑treated wild‑type aged mice will exhibit increased GluN2A/GluN2B ratio shift toward GluN2B in prefrontal synaptosomes, accompanied by elevated Nr4a1 mRNA and EAAT2 protein levels. These changes will not occur in PXR‑deficient neurons.
3. Electrophysiological – In vivo hippocampal‑prefrontal recordings will reveal a reduced mismatch negativity (MMN) amplitude baseline in aged animals, reflecting diminished surprise sensitivity. IPA treatment will restore MMN amplitude to young‑adult levels, an effect blocked by neuronal PXR deletion.
4. Pharmacological – Co‑administration of a PXR antagonist (e.g., ketoconazole) with IPA will abolish both behavioral and molecular rescue, confirming pathway specificity.

Experimental Design (Outline)

• Subjects: Young (3‑mo), aged vehicle, aged IPA, aged IPA + PXR antagonist, aged neuron‑specific PXR KO ± IPA.
• Timeline: 4‑week treatment, followed by behavioral testing (probabilistic reversal learning, novel object recognition).
• Assays: Western blot/qPCR for GluN2A/B, Nr4a1, EAAT2; ELISA for cytokines; extracellular glutamate measured via microdissection; in vivo EEG for MMN.
• Analysis: Two‑way ANOVA (age × treatment) with post‑hoc Tukey; significance set at p<0.05.

Potential Outcomes & Interpretation

• Support: IPA improves reversal learning, shifts NMDA subunit profile, enhances astrocytic glutamate uptake, and normalizes MMN only when neuronal PXR is present. This would substantiate the hypothesis that microbial metabolite signaling directly tunes synaptic plasticity parameters to counteract over‑consolidation.
• Refute: If IPA fails to improve flexibility despite confirmed brain uptake, or if effects persist in neuronal PXR knockouts, the proposed mechanism would be insufficient, suggesting alternative pathways (e.g., peripheral immune modulation) dominate the cognitive phenotype.

By linking a microbiota‑derived ligand to concrete synaptic regulators, this hypothesis transforms the notion of irreversible cognitive decline into a reversible state of excessive predictive confidence, amenable to metabolic intervention.